Singapore healthtech startup Lucence bags $20m in series A funding
Singapore-based healthtech startup Lucence has raised US$20 million in a series A round led by global healthcare provider IHH Healthcare. SGInnovate also participated in the round, along with existing investors such as Temasek Holdings subsidiary Heliconia Capital, Lim Kaling, and Koh Boon Hwee. Lucence uses liquid biopsy, a blood-based technology that’s less invasive than tissue biopsies, to help clinicians analyze…